Clinical trials
Recruiting Thrombosis trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ottawa Hospital Research Institute | 4 |
| Regeneron Pharmaceuticals | 2 |
| Damian Ratano | 1 |
| Helsinki University Central Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombosis | 8 |
| Hemorrhage | 4 |
| Atrial Fibrillation | 3 |
| Venous Thromboembolism | 3 |
| Gastrointestinal Hemorrhage | 1 |
| Ischemic Stroke | 1 |
| Neoplasms | 1 |
| Pancreatic Neoplasms | 1 |
| Postthrombotic Syndrome | 1 |
| Pulmonary Embolism | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.